AstraZeneca (NASDAQ: AZN) has overhauled its local management in China, replacing Michael Lai with Alex Lin as the country’s general
1 year ago
SHANGHAI – AstraZeneca’s (NASDAQ: AZN) blockbuster breast cancer drug Enhertu will be added to China’s state-run health insurance scheme from
LONDON – AstraZeneca’s (NASDAQ: AZN) China president Leon Wang, who was detained last month by Chinese authorities, is in touch
LONDON – On Wednesday, AstraZeneca (NASDAQ: AZN) said its China president Leon Wang had been detained by Chinese authorities and,
AstraZeneca’s (NASDAQ: AZN) China president is under investigation and is cooperating with Chinese authorities, the company said on Wednesday, sending
On Monday, AstraZeneca (NASDAQ: AZN) said it would pay up to $1.92 billion to CSPC Pharmaceutical Group Ltd in an
AstraZeneca (NASDAQ: AZN) shares fell in the pre-market trading Tuesday after results from the company’s lung cancer trials showed that
LONDON – Detailed results from one of AstraZeneca’s (NASDAQ: AZN) key lung cancer trials released on Monday showed that its
Police in China have detained five current and former employees of AstraZeneca (NASDAQ: AZN) for questioning about potential illegal activities,
AstraZeneca (NASDAQ: AZN) has warned it could relocate its vaccine manufacturing site from the UK to the United States as
On Tuesday, the U.S. Food and Drug Administration approved Johnson & Johnson’s (NYSE: JNJ) chemotherapy-free combination treatment for a type
On Thursday, AstraZeneca (NASDAQ: AZN) said the U.S. Food and Drug Administration (FDA) has granted its blockbuster cancer drug Imfinzi
